Dépôt Institutionnel de l'Université Ferhat ABBAS - Sétif 1 >
Faculté de Technologie >
Département de Génie des Procédés >
Thèses de doctorat >

Veuillez utiliser cette adresse pour citer ce document : http://dspace.univ-setif.dz:8888/jspui/handle/123456789/4024

Titre: In-silico drug discovery of new potential NF-κB (nuclear factor-kappa B) inhibitors, using the computer aided drug design tools
Auteur(s): Hammoudi, Nour el houda
Mots-clés: NF-κB
Date de publication: 13-oct-2022
Résumé: The Inhibition of IKK-β(nuclear factor kappa B kinase subunit beta),a specific modulator of NF-κB(nuclear factor-κB),is considered a valid target to discover new active compounds for various cancers and rheumatoid arthritis treatment.The aim of this work is twofold:Firstly, to develop new designed compounds IKK-β inhibitors using different computer aided drug design tools (QSAR, Molecular Docking,Molecular Dynamics and drug likeness evaluation).The analysis of the results of QSAR model and molecular docking succeeded to screen 21 interesting compounds with better inhibitory concentration having a good affinity to IKK-β. Secondly, is to develop new predictive QSAR models for the〖pIC〗_50 of of nuclear factor-κB(NF-κB)inhibitors prediction, based on machine learning methods.Based on the statistical analyses,it was found that the obtained[]ANN model is reliable,robust and showed the better predictive ability compared to the MLR model.Thus,the []ANN model can be used quite satisfactorily for the prediction and screening of a new series of nuclear factor-κB(NF-κB) inhibitors.
URI/URL: http://dspace.univ-setif.dz:8888/jspui/handle/123456789/4024
Collection(s) :Thèses de doctorat

Fichier(s) constituant ce document :

Fichier Description TailleFormat
Phd Thesis Hammoudi.pdf6,39 MBAdobe PDFVoir/Ouvrir
View Statistics

Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.


Valid XHTML 1.0! Ce site utilise l'application DSpace, Version 1.4.1 - Commentaires